Intertwined dimeric structure for the SH3 domain of the c-Src tyrosine kinase induced by polyethylene glycol binding  by Cámara-Artigas, Ana et al.
FEBS Letters 583 (2009) 749–753journal homepage: www.FEBSLetters .orgIntertwined dimeric structure for the SH3 domain of the c-Src tyrosine kinase
induced by polyethylene glycol binding
Ana Cámara-Artigas b,*, José M. Martín-García a, Bertrand Morel a, Javier Ruiz-Sanz a, Irene Luque a
aDepartment of Physical Chemistry and Institute of Biotechnology, Faculty of Sciences, University of Granada, 18071 Granada, Spain
bDepartment of Physical Chemistry, Biochemistry and Inorganic Chemistry, University of Almería, Carretera Sacramento s/n, 04120 Almería, Spaina r t i c l e i n f o
Article history:
Received 15 December 2008
Revised 19 January 2009
Accepted 20 January 2009
Available online 29 January 2009
Edited by Richard Cogdell
Keywords:
Src Homology 3 domains
X-ray structure
Loop ﬂexibility
Domain swapping
Intertwined dimer
c-Src Tyrosine kinase0014-5793/$34.00  2009 Federation of European Bio
doi:10.1016/j.febslet.2009.01.036
Abbreviations: SH3, Src Homology 3; c-Src-SH3, SH
tyrosine kinase; PPII, left handed polyproline II
thiogalactopyranoside; DLS, dynamic light scattering
* Corresponding author. Fax: +34 950 015008.
E-mail address: acamara@ual.es (A. Cámara-Artigaa b s t r a c t
Here we report the ﬁrst crystal structure of the SH3 domain of the cellular Src tyrosine kinase (c-Src-
SH3) domain on its own. In the crystal two molecules of c-Src-SH3 exchange their –RT loops gener-
ating an intertwined dimer, in which the two SH3 units, preserving the binding site conﬁguration,
are oriented to allow simultaneous binding of two ligand molecules. The dimerization of c-Src-SH3
is induced, both in the crystal and in solution, by the binding of a PEG molecule at the dimer inter-
face, indicating that this type of conformations are energetically close to the native structure. These
results have important implications respect to in vivo oligomerization and amyloid aggregation.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Src Homology 3 (SH3) (Src Homology 3) domains are wide-
spread proline-rich recognition modules, found in many different
proteins, in diverse numbers and combinations. These domains
are implicated in deregulated signaling pathways during cancer
development and are also associated to other pathologies such as
AIDS, osteoporosis, or inﬂammatory processes [1,2]. SH3 domains
are small (60–80 residues) monomeric protein modules that fold
cooperatively with no signiﬁcant accumulation of intermediates
into a b-barrel structure composed of two orthogonal anti-parallel
b-sheets of three and two strands, connected by three main loops
(–RT, n-Src and the distal loops). The binding site is a shallow
groove that contains two hydrophobic pockets formed by highly
conserved aromatic residues in the domain and a third pocket,
responsible for binding speciﬁcity, formed by the –RT and n-Src
loops, which are highly variable in sequence. SH3 domains interact
with proline-rich sequences typically containing an xPxxP motif
and bind in a PPII conformation so that each of the xP moietieschemical Societies. Published by E
3 domain of the cellular Src
helix; IPTG, isopropyl-b-D-
s).packs tightly into one of the two hydrophobic pockets at the bind-
ing site [2].
Typically, SH3 domains act as docking sites for the recruitment
of substrates and the formation of supra-molecular complexes
leading to the enzymatic modiﬁcation of some of their compo-
nents. However, in some cases, they also play an essential role in
the regulation of the enzymatic activity of the proteins that contain
these domains. This is the case of the Src family of tyrosine kinases,
which comprises a subclass of membrane-associated non-receptor
tyrosine kinases involved in cellular signal transduction pathways,
and are frequently over-expressed and/or aberrantly activated in a
variety of cancers [3]. There are 11 members of the family, c-Src, c-
Yes, Fyn, Lyn, Lck, Hck, Blk, Blk, Fgr, Srm and Yrk, which share a
common domain architecture including one SH3 domain responsi-
ble for the regulation of the kinase activity and the recruitment of
substrates [4]. Although these kinases have been postulated to per-
form redundant functions in the cell, their implication in tumour
development is different and there is an increasing body of evi-
dence for speciﬁcity in signaling, in some instances determined
by interactions mediated by their SH3 domains [5]. Thus, the elu-
cidation of the molecular components of binding speciﬁcity be-
tween these domains would clearly beneﬁt from high resolution
structural studies.
We present here the ﬁrst high-resolution structure of the free
SH3 domain of the cellular Src tyrosine kinase (c-Src-SH3) domainlsevier B.V. All rights reserved.
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dences of aggregation had been previously observed in solution,
c-Src-SH3 crystallizes as an intertwined dimer induced by the
presence of PEG300. The fact that this intertwined dimeric confor-
mation is sufﬁciently stabilized by small-molecule binding as to
become the predominant specie in solution has important implica-
tions with respect to the biological signiﬁcance of SH3
oligomerization.2. Materials and methods
2.1. Cloning, expression and puriﬁcation of Src-SH3 domain
The plasmid pET15b containing the chicken c-Src-SH3 domain
gene was a generous gift from Dr. E. Freire (Johns Hopkins Univer-
sity). Plasmid-encoded c-Src-SH3 domain was expressed in Esche-
richia coli BL21(DE3) strain (Novagen) with a N-terminal 6xHis
tag and an engineered thrombin cleavage site. The protein was
puriﬁed by the standard protocol. Protein purity and concentration
was determined as described previously [6].
2.2. Crystallization and data collection
As a standard crystallization procedure, 4 lL droplets were
prepared by mixing 2 lL of protein solution (10 mg mL1 in
10 mM Tris buffer at pH 8.0) and 2 lL of reservoir solution. The
mixture was vapour equilibrated against 1 mL of reservoir solu-
tion. The best crystals were obtained in 1.7 M ammonium sulfate,
5% PEG 300, 10% glycerol and 0.1 M sodium acetate at pH 5. Un-
der these conditions, crystals typically appear within one to two
months. For data collection crystals were looped and placed in a
cold nitrogen stream maintained at 110 K. X-ray diffraction data
collection was performed at the beamline BM-16 station of the
European Synchrotron Radiation Facility (ESRF) using a 0.97 Å
wavelength in a Mar CCD-165 detector. Data were indexed, inte-
grated and scaled with the HKL2000 suite [7]. The crystallo-
graphic parameters and statistics of the data collection are
listed in Table 1.Table 1
Data collection and Reﬁnement statistics.
Space group P65 Protein residues 114
Unit cell
dimensions
Solvent (water) 49
a, b, c 46.596, 46.596,
128.064
Rwork (%) 20.6
(23.7)
a, b, c 90, 90, 120 Rfree (%) 22.2
(32.7)
Resolution
range (Å)
20–1.65 RMS deviations from
ideal geometry
Number of
observations
139443 (20198) Bonds (Å) 0.010
Unique reﬂections 19633 (2835) Angles (degrees) 2.029
Data completeness
(%)
95.5 (94.9) Mean B (protein)
(Å2)
Multiplicity 7.1 (7.1) Main chain A 18.7
B Wilson plot (Å2) 22.63 Main chain B 18.2
Rmerge
b (%) 7.6 (54.6) Side chain A 21.5
I/r(I) 21.7 (2.7) Side chain B 20.9
Vm (Å3 Da1) 2.97 Residues in most
favored regions of
Ramachandran
plot (%)c
100%
Solvent content (%) 58.65
aThe values in parentheses are for the highest resolution bin.
b Rmerge =
P
hk
P
li|IihIi|/|hIi|, where Ii is the intensity for the ith measurement of
an equivalent reﬂection with indices h, k, l.
c From program PROCHECK [12].2.3. Structure resolution and reﬁnement
Initial phasing was performed using Molrep [8]. The coordinates
of the c-Src-SH3 NMR average models as well as the crystallo-
graphic models of the Fyn-SH3 (unpublished results) and the c-
Yes-SH3 domain [6], without ligand and water molecules, were
used as a search model. No model produced a clear peak although
the best results were obtained using the coordinates of the c-Yes-
SH3 domain, which yields two peaks with a value around 4r. The
translation function gave a dimer composed by the two ﬁrst peaks
of the rotation function with an initial R-factor of 55% but the ini-
tial reﬁnement using 10 cycles of restrained positional reﬁnement
with the program REFMAC5 quickly dropped the R factor to 34%.
Manual building was performed using the resulting rA-weighted
(2Fo–Fc) and (Fo–Fc) electron density maps and the program COOT
[9]. Once all the backbone and side chains were built and correctly
positioned in the electronic density map the model reached an R-
factor below 30%. The ﬁnal step of the reﬁnement was carried
out with REFMAC5 together with the ARP/wARP v5.0 program from
the CCP4 suite [10] to place the water molecules in the electron
density difference maps. Besides water molecules, several solvent
molecules were clearly identiﬁed in the electron density difference
maps: one sulfate ion, one glycerol, three acetate and three PEG
molecules. Before deposition the quality of the structure was
checked using the MolProbity web server [11] and PROCHECK
[12]. Reﬁnement statistics are collected in Table 1.
Structure superposition and RMSD calculations were performed
using the CCP4 modules LSQKAB and TOP [10]. Protein interfaces in
the crystal were characterized using the PISA server [13]. Distances
between amino acids were calculated using the program CONTACT
from CCP4 Suite [10]. The coordinates and structure factors were
deposited at the RCSB PDB with entry code 3FJ5.
2.4. Dynamic light scattering
DLS measurements were performed with a DynaPro MS-X
instrument (Wyatt Technology Corporation, Santa Barbara, CA,
USA) using a thermostatized 30 lL quartz sample cuvette. Samples
of c-Src-SH3 domain were prepared at two different concentra-
tions (2 mg mL1 and 10.3 mg mL1) in 100 mM sodium acetate
pH 5.0 and 50 mM sodium phosphate pH 8.0. Immediately before
measurements protein solutions were centrifuged for 30 min at
14000 rpm, 4 C, in order to remove any aggregates and dust. Sev-
eral DLS measurements were performed on each sample over
5 weeks of incubation at 15 C.3. Results and discussion
3.1. c-Src-SH3 crystallizes as an intertwined dimer
The ﬁrst crystallographic structure of the isolated SH3 domain
of the c-Src tyrosine kinase has been solved at 1.65 Å. The asym-
metric unit contains two c-Src-SH3 molecules associated as an
intertwined dimer. The two chains, which are related by a non-
crystallographic two-fold axis, adopt very similar conformations
so that the backbone superposition yields an rmsd value of
0.116 Å. In the ﬁnal model, the n-Src loop of each molecule, con-
necting the second and third b-strands, undergoes a signiﬁcant
conformational change with respect to the canonical SH3 fold
and adopts an open conformation that allows the packing of the
C-terminal segment of one of the proteins into the N-terminal
region of the other. This domain swapping results in the generation
of two prototypic SH3 structures with similar interfaces between
the two b-sheets (Fig. 1A). Also, in both structures, the geometry
and orientation of the aromatic side-chains deﬁning the binding
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ical SH3 domain. In fact, the superposition of the intertwined di-
mer structure with previous NMR structures of the c-Src-SH3
domain in its free and bound forms [14–16], as well as the crystal-
lographic structure of the SH3 domain in the context of the full-
length human c-Src tyrosine kinase [17], clearly shows how the
only signiﬁcant differences are restricted to the loop regions
(Fig. 1B). These differences are similar to those observed when
comparing different SH3 domains from the Src family, and have
been associated to the high ﬂexibility of the n-Src and RT loops [6].
To date, domain swapping has only been experimentally de-
scribed for the SH3 domains of p47phox [18] and Eps8 [19]. In
the case of p47phox-SH3 the domain swapping takes place
through a conformational change in the distal loop. In the case of
both Eps8–SH3 and c-Src-SH3, for which the intertwined dimers
share the same pattern of exchanged secondary structure ele-
ments, the ﬂexibility of the n-Src loop, which acts as a hinge region,
seems to be determinant for the domain swapping. Nonetheless,
the changes in the w and / dihedral angles of residues in the n-
Src loop (a residue shorter in Eps8) are different in the Eps8 and
c-Src intertwined dimers and result in different orientations be-
tween the two chains. With the exception of Thr114 that maintains
its conformation, residues Val111 to Asp117 undergo considerable
changes (over 100 in many cases) in their U and W angles that
shift into the b-sheet region in the dimeric c-Src-SH3 structure.
These conformational changes are accompanied by a redistribution
of the hydrogen bonds established in the n-Src region, that have
been described to be important for the formation and stability of
the loop [20].
3.2. Role of PEG300 in dimer stabilization
The dimerization of c-Src-SH3 is associated to the formation of
an extensive interface containing a considerable number of stabi-
lizing interactions. Analysis of the dimeric interface using the PISA
server [13] shows that 48 and 49 residues from chain A and B,
respectively, are implicated in the establishment of 48 inter-chain
hydrogen bonds. Also, two salt bridges are observed in the inter-
face, one implicating Arg95 in the –RT loop and Glu115 in the n-
Src loop, and a weaker, water-mediated interaction established be-Fig. 1. (A) Intertwined dimeric structure of the SH3 domain of the cellular Src tyrosine k
respectively. In the lower panel the structure of one of the isolated SH3 chains is shown.
1PRM, 1QWE, 1QWF, 1RLP, 1RLQ, 1SRL and 1SRM). As can be seen in this ribbon represtween Glu106 and Arg128 at the distal loop, which is also impli-
cated in a hydrogen bond with Ser101 of the opposite chain.
Arg128 is one of the two sites at which the chicken and human se-
quences of c-Src SH3 differ (Thr125 and Arg128 in the chicken pro-
tein are Ser and Gln respectively in the human sequence). It is
worth noting that position 128 is highly variable amongst the dif-
ferent SH3 domains from the Src family and seems to be implicated
in long-range cooperative effects within the domain, so that muta-
tions at this position have a signiﬁcant impact on the binding ener-
getics [21]. The water-mediated salt bridge observed between
Glu106 at the –RT loop and Arg128 provides a link between the
distal loop and the binding site that can play an important role
in the binding afﬁnity.
The nature of the interactions that stabilize the dimeric confor-
mations are also different in Eps8–SH3 and c-Src-SH3 intertwined
structures. The Eps8–SH3 dimer interface resembles the central
core of the globular protein, containing tightly packed aromatic
residues from both chains that favor the electrostatic interaction
between the aromatic rings (Fig. 2A). Also, the number of charged
residues and, consequently, of inter- and intra-chain salt bridges, is
much higher in the Eps8–SH3 intertwined dimer than in c-Src-SH3.
The inﬂuence of electrostatic interactions in this system is clearly
illustrated by the fact that at low pH, where glutamic residues
are protonated, Eps8–SH3 is monomeric. The situation is different
for the c-Src-SH3 intertwined dimer, which seems to rely more
strongly on the establishment of interfacial hydrogen bonds. In
fact, the high quality of the data used to solve this structure allows
us to model a low molecular weight PEG, present in the crystalliza-
tion solution, at the dimer interface (Fig. 2B).
We tested the relevance of the interactions established by the
PEG molecule in solution with a set of DLS experiments that were
conducted at several concentrations of protein and different pH
values both in the presence and absence of PEG300. In the absence
of PEG300, the only species in solution has a hydrodynamic radius
of 1.6–1.8 nm at all protein concentrations. This radius is compara-
ble to that reported for a-Spc SH3 domain, which remains
monomeric at very high protein concentrations [22] and is in good
agreement with the fact that no signs of dimerization for the c-Src-
SH3 in solution are observed at any concentration. On the other
hand, upon addition of PEG300 to the solution the hydrodynamicinase (c-Src-SH3) domain in which chains A and B are coloured in green and cyan,
(B) Superposition of all Src-SH3 structures available to date (PDB codes: 2SRC, 1PRL,
entation, the major differences are present at the RT-loop and Src-loop.
Fig. 2. (A) Dimer interface at the c-Src-SH3 (green) and Eps8-SH3 (yellow) intertwined dimers. (B) Detail of the buried water molecules at the c-Src-SH3 (green) and Eps8-
SH3 (yellow) intertwined dimer structures. Buried water molecules are color according to their solvent accessibilitiy (0 Å2 in red, 5 Å2 in blue and 10 Å2 in cyan).
Fig. 3. Superposition of the crystal structure of the c-Src SH3 domain in the full-
length tyrosine kinase (PDB entry 2SRC, red) and the c-Src-SH3 domain intertwined
dimer structure (chain A orange, chain B pale orange). Residues deﬁning the
canonical PPII binding site are shown as sticks and the peptide at the binding site on
chain A is shown as ribbon (modeled from the NMR PDB entry 1PRL).
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populated species (100%) is a dimer. The formation of the dimeric
conformation is a relatively fast process that is completed within
few minutes. In all cases the radius does not evolve upon extended
incubation and no signiﬁcant aggregation was observed after
38 days of incubation at 15 C. These results clearly indicate that,
under these conditions, the interactions mediated by the PEG mol-
ecule are necessary and sufﬁcient for the stabilization of the inter-
twined dimeric conformation.
3.3. The binding site of the c-Src-SH3 intertwined dimer
SH3 domains act as molecular recognition modules that interact
with proline-rich sequences in a PPII conformation. In c-Src-SH3 the
ﬁrst pocket for PPII recognition is formed by the highly conserved
residues Tyr90 and Tyr136 and the second pocket by Tyr92,
Tyr136 and Trp118. Asp99 is a very signiﬁcant residue in the spec-
iﬁcity pocket that, in many complexes, establishes a salt bridge
with basic residues (frequently Arg) in the ligand and determines
the binding orientation [14]. As illustrated in Fig. 3, the conforma-
tions of these residues in the intertwined dimeric structure of c-
Src-SH3 are very similar to those observed in the crystal structure
of this domain in the context of the full-length c-Src kinase (PDB en-
try 2SRC). This clearly indicates that the integrity and properties of
the binding site are preserved in the swapped dimer though, in this
case, the PPII binding pockets contain residues from two different
chains. Moreover, in contrast with the Eps8 intertwined dimer, in
which the binding groove of eachmonomer is included in the dimer
interface and thus inaccessible to the ligand, the orientation of the
two SH3 structures in the c-Src-SH3 intertwined dimer is such that
the binding sites are exposed to the solvent allowing the simulta-
neous binding of two peptide ligands. Studies to determine the
behavior of the c-Src-SH3 intertwined dimer structure in presence
of several ligands are currently in progress.3.4. Domain swapping and amyloid formation
Domain swapping has been proposed as a feasible aggregation
mechanism for the elongation of amyloid ﬁbrils [23–25]. In fact,
molecular dynamics simulation studies of amyloidogenesis with
the c-Src-SH3 domain predicted the formation of two different
types of aggregates: an open aggregate that propagates upon pack-
ing of the –RT loops of the monomers by swapping of the two
strands in the loop and a closed-aggregate consisting of an inter-
twined dimeric structure in which both monomers exchange their
respective –RT loops [26]. Our results provide experimental valida-
tion to this model proving the existence of a closed dimeric struc-
ture in solution that is stabilized by the interactions provided by
the PEG molecule. Even though we did not ﬁnd experimental
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tions studied, the fact that this dimeric intertwined structure can
be stabilized by a few additional hydrogen bonds established at
the interface has important functional implications since it clearly
indicates that these conformations are low-energy states, within a
few kJ mol1 from the prototypical SH3 structure in the native
state conformational ensemble that can be sufﬁciently stabilized
as to become the predominant species under physiological condi-
tions by changes in pH, salt concentration or binding of the appro-
priate ligand.
Three SH3 domains have now been reported to aggregate into
amyloid ﬁbrils in vitro [6,22,27]. The mechanism underlying the
aggregation phenomenon conducting the formation of amyloid ﬁ-
brils is still poorly understood and, due to the difﬁculties inherent
to amyloid ﬁbril crystallization, the structural information about
this type of aggregate is still very scarce. From their molecular
dynamics analysis, Ding et al. proposed the existence of partially
folded conformations in the denatured state of c-Src-SH3 and
two competing processes: folding and aggregation [26]. According
to their model, the amyloid structure is propagated by the ex-
change of strands in the –RT loop, which has been shown to consti-
tute a stable element in partially folded states of c-Src-SH3, and to
play an important role in its folding kinetics. Although up to date
we do not have experimental evidence of amyloid ﬁbril formation
by the c-Src SH3 domain, we have previously reported amyloid
aggregation for the SH3 domain of the closely related c-Yes tyro-
sine kinase [6]. We found amyloid formation in this system to be
strongly pH dependent and proposed the ionization state of a clus-
ter of acidic residues closely located to positively charged amino
acids to be determinant for aggregation. These residues are con-
served in the SH3 domain of c-Src, suggesting that a similar mech-
anism might be applicable. In fact, in the crystal structure
presented here, Arg95 at the –RT loop of c-Src-SH3 stabilizes the
intertwined dimer through the formation of a salt bridge with
Glu115 in the n-Src loop of the opposite chain and is also placed
at hydrogen bond distance of the interfacial PEG molecule. More-
over, Glu106 is implicated in several intra- and inter-chain hydro-
gen bonds and a weak salt bridge with Arg128 of the opposite
chain. In fact, studies carried out with Alzheimer’s b-amyloid pep-
tides show that the modulation of electrostatic interactions by
changes in pH can play an important role in the aggregation of
small intracellular oligomers (dimers or trimers) that, once re-
leased into the extracellular medium, can act as seeds to accelerate
ﬁbril formation [23,24].
In summary, our results show that dimeric structures based on
the exchange of secondary structure elements upon conforma-
tional changes in the SH3 loops are low energy conformations that
can be sufﬁciently stabilized by the presence of small molecules
in vitro but that could also induce amyloidogenesis in vivo under
the appropriate set of conditions.
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